Morgan Stanley cuts PT, earnings view for Australia's Healius

Healius

01/09/2023 04:10

** Analysts at Morgan Stanley cut PT on Australia's Healius
 HLS.AX  to A$2.60 from A$2.50, keep "underweight" rating
    ** HLS stock falls as much as 2% to A$2.745
    ** Healthcare co swings to FY loss from profit last year
    ** MS cuts EPS est. for co by 41% and 33% for FY24 and FY25,
respectively; cites lower COVID-19 testing and higher net
interest
    ** Adds, costs in HLS' main pathology division remain
greater than anticipated
    ** As of last close, stock down 8.8% this year

 (Reporting by Himanshi Akhand in Bengaluru)
 ((Himanshi.Akhand@thomsonreuters.com;))